b.correia
TL2 Moderator · Nijmegen
Contributes reviews on supplier material. Based in Nijmegen.
Joined 14 February 2025 · last posted 1d
84 posts, newest first. Showing up to 150.
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #57 · Analytics › Home & field testing · 27 Jul 2026 · 4 likes post #56 is right about the mechanism and I think understates the practical bit. Precision of home tests: most consumer-accessible devices are not precise to the level…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #75 · Access › International · 12 Jul 2026 · 1 like Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #69 · Analytics › Impurities & related substances · 12 Jul 2026 · 2 likes Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a chemical modification that occurs during storage.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #12 · Access › Insurance & coverage · 9 Jul 2026 · 1 like Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
What is genuinely unknown about long-term amylin agonism Replied, post #10 · Compounds › Cagrilintide & amylin analogues · 7 Jul 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Restarting after a long gap: what the labelling implies Replied, post #13 · Practice › Dosing & titration · 5 Jul 2026 · 32 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
What to include when your question involves a laboratory result — a second dataset Replied, post #3 · Start Here › How to Ask · 5 Jul 2026 · 33 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Pages past their review date, listed — does this still hold? Replied, post #33 · Meta › Wiki maintenance · 1 Jul 2026 · 0 likes On post #29 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
What a certificate commits its issuer to — the long version Replied, post #19 · Analytics › COA interpretation · 30 Jun 2026 · 0 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Personal or family history of medullary thyroid carcinoma Replied, post #7 · Safety › Contraindications · 22 Jun 2026 · 1 like I read post #5 twice before replying, because I had assumed the opposite. History of pancreatitis: these compounds can rarely trigger pancreatitis. History of…
-
Pooling trials with different estimands Replied, post #33 · Evidence › Meta-analyses · 18 Jun 2026 · 4 likes Worth separating two things that post #29 runs together. Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is…
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #29 · Documentation › Doc review · 17 Jun 2026 · 13 likes Worth separating two things that post #25 runs together. Citation checking: if a maintained page cites a paper, the citation should match what the paper actually says.…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #14 · Evidence › Trials · 13 Jun 2026 · 30 likes This follows post #11 rather than contradicting it. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude.…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #10 · Start Here › Welcome · 7 Jun 2026 · 10 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #133 · Compounds › Tirzepatide · 21 May 2026 · 1 like Coming back to post #131, because the follow-up matters more than the original answer. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes…
-
Transporting a vial for a weekend away — a second dataset Replied, post #46 · Practice › Storage & stability · 6 May 2026 · 20 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
-
A plateau that disappeared when I changed how I measured Replied, post #31 · Outcomes › Progress reports · 10 Apr 2026 · 6 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Spike-and-recover accuracy for a peptide assay Replied, post #48 · Analytics › Method validation · 8 Apr 2026 · 12 likes I read post #46 twice before replying, because I had assumed the opposite. Robustness: the method gives consistent results when minor parameters vary. Tested by…
-
The "under review" status pill and when a moderator applies it Replied, post #57 · Evidence › Preprints · 6 Apr 2026 · 10 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #42 · Analytics › Mass spectrometry · 30 Mar 2026 · 13 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #56 · Practice › Side effects · 14 Mar 2026 · 15 likes Coming back to post #54, because the follow-up matters more than the original answer. Fatigue: commonly reported, frequently multifactorial. It is worth asking whether…
-
The lowest dose that does anything: is that a real question? Replied, post #87 · Practice › Dosing & titration · 7 Mar 2026 · 0 likes post #86 is right about the mechanism and I think understates the practical bit. Splitting a weekly dose in two: the pharmacokinetic argument against is that you want…
-
The lowest dose that does anything: is that a real question? Replied, post #62 · Practice › Dosing & titration · 5 Mar 2026 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Cost per delivered dose, which is the number that matters Replied, post #53 · Access › Pricing · 2 Mar 2026 · 0 likes Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose, vial volume, and whether you are using a vial or a pen.
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #18 · Research Methods › N-of-1 designs · 26 Feb 2026 · 8 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #107 · Clinical › Special populations · 22 Feb 2026 · 28 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
Constipation management, with a dietitian's contribution Replied, post #32 · Practice › Side effects · 21 Feb 2026 · 0 likes Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #7 · Sourcing › Red flags · 18 Feb 2026 · 0 likes On post #3 — agreed on the reasoning, with one qualification. Inconsistency across documents: a certificate stating one purity, a website claiming another, and a…
-
[2026 update] What a purity-only report leaves out Replied, post #28 · Sourcing › Independent verification · 17 Feb 2026 · 4 likes post #27 is right about the mechanism and I think understates the practical bit. Service differences on vendor pages: Janoshik and Medutest results are measurements on…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #28 · Practice › Dosing & titration · 16 Feb 2026 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #115 · Analytics › Mass spectrometry · 15 Feb 2026 · 15 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #89 · Documentation › Wiki requests · 14 Feb 2026 · 1 like Coming back to post #87, because the follow-up matters more than the original answer. Format suggestions: if you think a maintained page could be clearer in its…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #45 · Evidence › Study critique · 11 Feb 2026 · 2 likes Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is…
-
Oral semaglutide bioavailability and its variability between people Replied, post #32 · Compounds › Oral incretins · 3 Feb 2026 · 1 like post #31 answers the question as asked. The question underneath it is different. Why an oral formulation is a formulation achievement: the molecule is the same but the…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #21 · Data & Tools › Datasets · 1 Feb 2026 · 1 like This follows post #18 rather than contradicting it. Privacy: if contributing data, only share data you are comfortable making permanent and public. Once posted, data is…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #111 · Clinical › Special populations · 27 Jan 2026 · 4 likes Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
-
[2026 update] What a purity-only report leaves out Started this topic · Sourcing › Independent verification · 12 Jan 2026 · 0 likes The question in the title: What a purity-only report leaves out I will give what I have already checked below so nobody repeats it. Structured report rather than an…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #7 · Outcomes › Body composition · 28 Dec 2025 · 3 likes post #6 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Liver enzymes drifting down and what that usually means Replied, post #37 · Clinical › Bloodwork · 16 Dec 2025 · 6 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
EU-wide position versus national implementation — what changed since Replied, post #10 · Regional › European Union · 14 Dec 2025 · 0 likes Cross-border purchase rules: buying a prescription in one EU country and bringing it home is complex. The substance is legal but crossing borders with it requires…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #73 · Analytics › Home & field testing · 8 Dec 2025 · 23 likes On post #69 — agreed on the reasoning, with one qualification. Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #93 · Compounds › Other compounds · 26 Nov 2025 · 12 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #20 · Sourcing › Regulatory · 24 Nov 2025 · 2 likes Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.
-
Guidelines revision: what changed and why — one year on Replied, post #29 · Meta › Announcements · 26 Oct 2025 · 1 like post #28 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Amylin receptor signalling and satiety Replied, post #2 · Pharmacology › Receptor biology · 18 Oct 2025 · 0 likes the opening post answers the question as asked. The question underneath it is different. Central versus peripheral action: GLP-1 agonism works through both central…
-
Sleep quality changes during weight loss — what changed since Replied, post #29 · Wellbeing › Sleep · 16 Oct 2025 · 4 likes Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic monitoring (annually) during weight loss is prudent because severity changes.
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #79 · Analytics › Home & field testing · 15 Oct 2025 · 0 likes Worth separating two things that post #75 runs together. Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result…
-
The anatomy of a question that gets answered within an hour — the long version Started this topic · Start Here › How to Ask · 14 Oct 2025 · 47 likes The anatomy of a question that gets answered within an hour — the long version Writing it up because I had to work it out twice and would rather nobody else did.…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #88 · Compounds › Cagrilintide & amylin analogues · 5 Oct 2025 · 1 like Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #134 · Practice › Reconstitution · 28 Sep 2025 · 4 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #143 · Practice › Storage & stability · 17 Sep 2025 · 1 like Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters…
-
Are there stupid questions here? A staff answer, at length Replied, post #149 · Start Here › Welcome · 4 Sep 2025 · 12 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #45 · Practice › Administration · 3 Sep 2025 · 0 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #17 · Analytics › Method validation · 27 Aug 2025 · 0 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
Micronutrient status when intake falls substantially Replied, post #21 · Clinical › Bloodwork · 1 Aug 2025 · 23 likes post #20 is right about the mechanism and I think understates the practical bit. Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things.…
-
What this community means by "a source", in practical terms Replied, post #41 · Start Here › Welcome · 20 Jul 2025 · 0 likes This follows post #38 rather than contradicting it. Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #90 · Nutrition & Training › Protein & intake · 14 Jun 2025 · 9 likes Picking up post #87: that is the part I would want checked first. Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be…
-
Coming back to: Getting a referral rather than a refusal Replied, post #57 · Clinical › Prescriber conversations · 11 Jun 2025 · 22 likes How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this shows X benefit in people with my condition; would it be…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #91 · Outcomes › Body composition · 24 May 2025 · 2 likes Lean mass loss during rapid weight reduction: depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
A well-designed study with a badly written abstract Replied, post #103 · Evidence › Study critique · 24 May 2025 · 11 likes Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question.…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #72 · Outcomes › Body composition · 21 May 2025 · 2 likes Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That distinction might matter but requires different imaging to measure.
-
The C-cell question: rodent findings and their human context Replied, post #18 · Compounds › Semaglutide · 19 May 2025 · 8 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Follow-up: Documentation that appears only after payment Replied, post #13 · Sourcing › Red flags · 22 Apr 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Retatrutide dose escalation in the published trials Replied, post #96 · Compounds › Retatrutide · 6 Apr 2025 · 0 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #128 · Analytics › COA interpretation · 26 Mar 2025 · 0 likes Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The difference between a TFA salt and an acetate salt can be…
-
Charge states for a 4 kDa peptide, worked through Replied, post #70 · Analytics › Mass spectrometry · 10 Mar 2025 · 1 like On post #66 — agreed on the reasoning, with one qualification. Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #28 · Practice › Reconstitution · 8 Mar 2025 · 5 likes Worth separating two things that post #24 runs together. A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #13 · Compounds › Cagrilintide & amylin analogues · 24 Feb 2025 · 22 likes Worth separating two things that post #9 runs together. Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #16 · Compounds › Retatrutide · 18 Feb 2025 · 30 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
-
Consistent declarations and why they matter more than clever ones Replied, post #24 · Sourcing › Logistics · 12 Feb 2025 · 0 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
When "no data" is the complete and final answer Replied, post #87 · Compounds › Other compounds · 8 Feb 2025 · 0 likes post #86 is right about the mechanism and I think understates the practical bit. When "no data" is the complete and final answer: if there is no published human data on…
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #20 · Sourcing › Vendor reports · 6 Jan 2025 · 0 likes This follows post #17 rather than contradicting it. Structured report format: compound, lot, independent testing service, method as reported, result, and the…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #74 · Compounds › Semaglutide · 2 Jan 2025 · 0 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #9 · Compounds › Oral incretins · 31 Dec 2024 · 18 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #22 · Devices › Cold chain · 15 Dec 2024 · 1 like Temperature logging: devices that record temperature over time let you confirm cold chain was maintained. Useful if a shipment was delayed or if you are concerned about…
-
Body image changing more slowly than the body Replied, post #29 · Wellbeing › Mental health · 14 Dec 2024 · 1 like I read post #27 twice before replying, because I had assumed the opposite. Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #117 · Analytics › COA interpretation · 14 Nov 2024 · 17 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Time to steady state after a dose increase Replied, post #71 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
US compounding rules and how they changed Replied, post #3 · Regional › North America · 26 Sep 2024 · 0 likes United States: FDA licenses compounds. Prescribing and pharmacy practice are state-regulated. Compounds are prescription-only. Coverage is decided by individual plans,…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #38 · Sourcing › Independent verification · 5 Sep 2024 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #20 · Compounds › Retatrutide · 5 Sep 2024 · 5 likes Picking up post #17: that is the part I would want checked first. The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #8 · Practice › Administration · 4 Sep 2024 · 23 likes This follows post #5 rather than contradicting it. A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #24 · Evidence › Journal club · 23 Aug 2024 · 4 likes Coming back to post #22, because the follow-up matters more than the original answer. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the…
-
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #16 · Safety › Contraindications · 19 Jul 2024 · 8 likes This follows post #13 rather than contradicting it. Severe renal impairment (eGFR